BASF Q1 2026 Results Beat Expectations but Middle East Risks Loom Large; Goldman Sachs Reiterates Buy Rating

Overview

This report provides an analysis of BASF's financial results for the first quarter of 2026. The key takeaway is that although BASF delivered robust quarterly financials, exceeding expectations across the board thanks to strong execution and capacity expansion benefits, management's comments during the earnings call regarding the Middle East conflict have sparked deep concerns about supply chain disruptions and potential demand destruction. Goldman Sachs believes this geopolitical uncertainty will exert downward pressure on the stock price, potentially spilling over into the broader European chemical sector. Nevertheless, based on long-term valuation fundamentals, Goldman Sachs maintains its 'buy' rating on BASF.

Core views

Firstly, from a financial perspective, BASF posted impressive results in Q1 2026. Adjusted EBITDA reached €2.356 billion, 8% above Vara consensus estimates, while sales totaled €16.0 billion, slightly beating expectations. This outperformance was primarily driven by strong volume growth rather than price increases. Group-wide sales volumes rose 4.3% year-over-year, significantly surpassing the consensus forecast of 1.9%. In particular, the chemicals segment saw an 11.4% surge in sales, fueled by expanded production capacity at the new Zhanjiang joint venture, while Surface Technologies and Industrial Solutions recorded notable gains of 11.5% and 1.1%, respectively. However, pricing remained weak, with overall prices down 1.2% year-over-year—especially in the chemicals segment, where prices plummeted 13.9%, reflecting limited ability to pass cost pressures downstream. Secondly, when examining individual segments, Materials and Surface Technologies were the primary sources of positive surprises, with adjusted EBITDA exceeding consensus estimates by 29% and 66%, respectively. By contrast, Agricultural Solutions and Corporate Lines underperformed, falling short of expectations by 3% and 51%, respectively. On the cash flow front, operating cash flow stood at -€797 million, an improvement compared to the same period last year, with a higher cash conversion rate. Thirdly, and most critically, management's outlook raises significant concerns. Amid ongoing uncertainties surrounding the Middle East conflict, BASF kept its full-year EBITDA guidance within the €6.2–7.0 billion range (with a midpoint around €6.5–6.6 billion), broadly aligning with Goldman Sachs' projections. Yet management explicitly noted that while there are no major near-term risks to production or supply, their initial assumptions may prove overly optimistic, highlighting potential downside risks. Goldman Sachs interprets this as evidence of management's apprehension regarding supply chain disruptions and demand destruction caused by geopolitical factors. Finally, Goldman Sachs views these developments as having substantial market implications. As the world's largest diversified chemical company, BASF's concerns could trigger broader pessimism across the European chemical industry, affecting peers such as Linde (LXS), Evonik (EVK), Lanxess (LAIXY/AKE), Syensqo (SYENS), and Clariant (CLN). Although the stock may experience short-term volatility due to panic selling, given BASF's long-term value proposition in China's Zhanjiang project and its current undervaluation, the firm remains confident in its long-term return potential.

Analysis framework

Goldman Sachs employs an analytical framework structured along three key steps: 'fundamental validation → risk identification → valuation repositioning.' First, the firm quantifies the company's operational execution by comparing actual results against both consensus estimates and its own forecasts, confirming that BASF has indeed 'beat expectations.' Second, it delves into the implicit messages behind management guidance, particularly linking 'neutral/conservative' wording with 'geopolitical events' to infer potential tail risks. Lastly, while acknowledging short-term bearish sentiment, Goldman Sachs applies a discounted cash flow model (DCF) to anchor long-term valuations, assessing whether current prices already reflect excessive reaction to near-term risks, thereby arriving at a 'buy' recommendation. This methodology underscores the ability to distinguish between cyclical fluctuations and structural risks amid complex macroeconomic conditions.

Methodology notes

• Valuation MethodologyEV/DACF Valuation

  Enterprise Value divided by Debt-Adjusted Free Cash Flow

  The report utilizes a 10.3x EV/DACF multiple for BASF, projecting forward-looking values for 2026 and 2027. This metric is commonly used in heavy asset industries like chemicals, as it strips away capital structure differences and better captures core business cash-generating capabilities. Analysts apply a premium factor of 1.03 over historical averages, reflecting upward revisions to future profitability expectations.

• Industry Analysis FrameworkSupply-demand framework

  Decomposing revenue changes through volume and price dynamics to diagnose underlying causes

  The report meticulously breaks down sales volume and price trends across business segments. For instance, while the chemicals segment reported an 11.4% increase in sales volume, prices plunged 13.9%. Such disaggregation helps investors determine whether growth stems from genuine market demand expansion (volume-driven) or merely inflationary price hikes (price-driven), enabling more accurate predictions of future earnings sustainability.

• Event Dynamics and Behavioral FinanceExpectation Gap/Expectation Management

  Analyzing discrepancies between management guidance and market consensus, and their impact on investor sentiment

  Despite reporting better-than-expected results, management refrained from raising full-year guidance, instead emphasizing 'downside risks' and 'potentially overly optimistic assumptions.' This 'good news in bad news' or 'cautious messaging' often triggers market reversals. Analysts keenly recognize this dynamic, anticipating short-term pullbacks even amid favorable fundamentals, as markets price in future uncertainties.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• BASF SE (BASFN.DE)

  Direct reference. Strong results but suppressed by geopolitical risks, presenting short-term mispricing opportunities.

  Strengths

  World's largest diversified chemical giant; significant sales growth driven by Zhanjiang capacity expansion; robust internal raw material trading network and approximately 90% local sourcing ratio, providing superior resilience compared to peers.

  Weaknesses

  Exposure to high European energy costs and regulatory burdens; some segments (e.g., agricultural solutions) underperform; limited pricing power.

  Comparison

  Compared to European peers (e.g., LXS, EVK), BASF faces greater geopolitical exposure but boasts stronger vertical integration.

  Risks

  Escalation of Middle East conflict leading to logistics disruptions; persistent weakness in European demand; intensifying competition from Chinese chemical producers.

• LXS (Linde plc)

  Indirect beneficiary/detractor logic: indirectly affected. As a major European chemical player, it may suffer from cascading market sentiment impacts.

• EVK (Evonik Industries)

  Indirectly affected. Belonging to the same European chemical sector, it too may feel ripple effects from geopolitical risk sentiment.

• AKE (Lanxess AG)

  Indirectly affected. Also part of the European chemical sector, subject to geopolitical risk-related sentiment shifts.

• SYENS (Syensqo)

  Indirectly affected. Part of the European chemical sector, exposed to geopolitical risk sentiment.

• CLN (Clariant)

  Indirectly affected. Also part of the European chemical sector, impacted by geopolitical risk sentiment.

Key data

• Q1 2026 Adjusted EBITDA€2,356 mnDown 5.6% year-over-year but 8% above Vara consensus estimates
• Q1 2026 Group Volumes+4.3%242 basis points above consensus (+1.9% expected)
• Q1 2026 Group Pricing-1.2%Below consensus (+0.4% expected)
• FY26 EBITDA Guidance€6.2–7.0 bnUnchanged, with Goldman Sachs projecting a midpoint around €6.5 bn
• Target Price€63.00Corresponding to 16.6% upside potential
• Valuation Multiple10.3x 2026/2027E EV/DACFBased on a historical average of 10.0x, increased by 3%

Impact & implications

In the short term, BASF's stock is expected to face headwinds due to supply chain concerns triggered by the Middle East conflict. Given BASF's standing in the industry, such negativity could spread to the broader European chemical sector, weighing on peers like LXS, EVK, AKE, and others. In the medium term, should the situation escalate further—resulting in Suez Canal blockages or sharp oil price swings—BASF's cost advantages (such as internal raw material trading and high local sourcing ratios) could serve as a competitive moat against rivals. Looking ahead, with the Zhanjiang plant fully ramped up, BASF's market share in Asia is poised to grow, bolstering its long-term cash flow generation capacity.

Risks

• Key end-market demand weaker than expected (automotive, construction, consumer goods), compounded by European recession or German industrial stagnation.
• If BASF consolidates European chemical assets, it could result in destructive M&A outcomes.
• Chinese chemical producers intensify competition on cost and capacity fronts.
• China's monetary and fiscal stimulus fails to effectively support domestic production and chemical demand.
• Zhanjiang plant ramp-up delays or persistently low profit margins reduce new business contribution below expectations.
• Inability to pass raw material cost inflation onto customers compresses upstream chemical profit margins.
• Agricultural end-markets weaken due to farmers' economic conditions or trade uncertainties.
• Rising energy costs, regulatory burdens, and capital flight continue to erode European chemical competitiveness structurally.
• Complete reopening of the Suez Canal lowers logistics costs and increases Asian chemical imports into Europe.

What to watch

• Analysts and the market will closely monitor the second-quarter run rate.
• Management's specific guidance during the earnings call regarding supply-demand dynamics in Q2 and beyond.
• The evolution of the Middle East conflict and its tangible impacts on global logistics and raw material prices.